Glean Urodynamics System

Main article: Urinary incontinence

2022: Announcement of a catheter-free system for diagnosing urinary tract diseases

California-based medical technology company Bright Uro introduced the Glean Urodynamics System, a catheter-free urinary tract testing system, on August 19, 2022. Urodynamics testing can help doctors diagnose and evaluate patients with lower urinary tract symptoms, including frequent urge to urinate and incontinence.

Commonly used tests can provide information about how well the bladder can store and remove fluid. However, the need for two catheters means that the patient must lie during the test, which prevents doctors from obtaining data when the patient is on an outpatient basis and engaged in daily activities. These problems were an incentive for Bright Uro to develop a system to measure Glean urination. Bright Uro also received funding in the amount of $6 million for the development of technology.

Glean Urodynamics System

Instead of catheters suspended from the bladder and rectum/vagina, Glean uses a small sensor that can be fully inserted into the bladder where it records pressure data. Glean uses advanced data analysis techniques, allowing for urodynamics assessments with one sensor in the bladder and no catheters suspended from the bladder and rectum/vagina. This means patients can stand, walk and do their usual things while the device collects data. At the end of the monitoring period, the sensor can be easily removed using a special thread. The doctor uses the app to wirelessly download and analyze the data.

Many doctors are looking forward to Glean's arrival as they believe it can provide more physiologically relevant data and offer deeper analysis for treatment decisions, says Derek Herrera, CEO of Bright Uro. If successful, Glean can improve outcomes and shorten the time to successful treatment, helping to ensure that the patient is prescribed optimal treatment. Our goal as a company is to provide physicians with actionable information to improve patient outcomes. For patients, this means they can find effective treatments faster and take back control of their lives.[1]

Notes